SUN-377 Efficacy of Low Dose Denosumab in Maintaining Bone Mineral Density in Postmenopausal Women with Osteoporosis: A Real World, Prospective Observational Study

Introduction: Denosumab, a fully human monoclonal antibody to RANK-ligand, has been shown to increase bone mineral density (BMD) and reduce the risk of hip, vertebral and non-vertebral fractures in postmenopausal women with osteoporosis (1-3). Varying doses of denosumab including 30mg/3months have d...

詳細記述

保存先:
書誌詳細
出版年:J Endocr Soc
主要な著者: Khan, Aliya Aziz, Alrob, Hajar Abu, M’Hiri, Iman, Said, Hosay, Hussain, Sharjil, Hweija, Ismail, Iqbal, Salman, Davison, Shawn K, Mihai, Romanovschi, Haneef, Hafsa, Qutub, Mona, Zariffeh, Heather
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2020
主題:
Bone and Mineral Metabolism
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7207611/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.1431
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料